From: Clinical warning of hemophagocytic syndrome caused by Epstein-Barr virus
AUC | 95%CI | P value | Cut-off point | sensitivity | specificity | |
---|---|---|---|---|---|---|
IgA(g/L) | 0.884 | 0.811–0.957 | < 0.001 | 0.965a | 88.00% | 73.20% |
IgM(g/L) | 0.889 | 0.793–0.984 | < 0.001 | 1.145a | 84.00% | 87.50% |
CD3 + (×109/L) | 0.920 | 0.843–0.996 | < 0.001 | 3.338a | 82.80% | 95.10% |
CD4 + (×109/L) | 0.877 | 0.797–0.957 | < 0.001 | 0.787a | 72.40% | 96.70% |
CD8 + (× 109/L) | 0.912 | 0.830–0.944 | < 0.001 | 1.526a | 82.80% | 95.10% |
CD3-CD19 + (×109/L) | 0.854 | 0.754–0.953 | < 0.001 | 0.327a | 72.40% | 93.40% |
NK(×109/L) | 0.929 | 0.857–1.000 | < 0.001 | 0.266a | 82.10% | 98.40% |
Plasma EBV-DNA load (copies/mL) | 0.838 | 0.686–0.989 | < 0.001 | 47,250.000b | 77.80% | 94.70% |
Total blood EBV-DNA load (copies/mL) | 0.715 | 0.578–0.851 | 0.003 | 1,660,000.000b | 64.00% | 79.60% |
D-Dimer (ug/L) | 0.905 | 0.809–1.000 | < 0.001 | 1721.500b | 88.90% | 90.20% |